Condition
Neovascular (Wet) Age-Related Macular Degeneration clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Neovascular (Wet) Age-Related Macular Degeneration clinical trials that are recruiting, at sites in 3 countries (most in United States (4), Puerto Rico (1), China (1)). By phase: Phase 1/2 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Neovascular (Wet) Age-Related Macular Degeneration clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| EYC-0305 in Neovascular (Wet) AMD: First-in-Patients Safety and Tolerability Study | Phase 1/2 | Beverly Hills, California and 6 other locations | Recruiting | May 14, 2026 |
| AIV007 Periocular Shot for Wet AMD | Phase 2 | Torrance, California and 1 other locations | Recruiting | Apr 29, 2026 |
| Long-term follow-up for patients with wet age-related macular degeneration receiving SKG0106 | — | Boston, Massachusetts and 9 other locations | Recruiting | Apr 4, 2024 |
| Treatment for wet age-related macular degeneration using 4D-150 | Phase 1/2 | Phoenix, Arizona and 25 other locations | Recruiting | Jan 19, 2022 |
All recruiting trials (4)
-
EYC-0305 in Neovascular (Wet) AMD: First-in-Patients Safety and Tolerability Study
This study tests whether EYC-0305 given as an eye injection every 24 weeks is safe and tolerable in people 50 and older with wet AMD.
-
AIV007 Periocular Shot for Wet AMD
This trial tests whether a periocular injection of AIV007 can improve vision and safety in people with wet age-related macular degeneration, compared with the standard Eylea injections.
-
Long-term follow-up for patients with wet age-related macular degeneration receiving SKG0106
This study is testing how well and safely the treatment SKG0106 works for people with wet age-related macular degeneration over a long period after their last injection.
-
Treatment for wet age-related macular degeneration using 4D-150
This study is testing a new gene therapy called 4D-150 to see if it can improve vision in adults with wet age-related macular degeneration who are already receiving other treatments.
Quick answers
How many Neovascular (Wet) Age-Related Macular Degeneration clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (4 trials), Puerto Rico (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.